Yibigan® Insulin Glargine Injection
Indications:
Treatment of Type 1 diabetes mellitus and Type 2 diabetes mellitus in adults requiring insulin therapy; and Type 1 diabetes mellitus in adolescents and children aged 6 years and older.
Strength:300 units (pen refill)
National Drug Approval Number:S20210042
粤ICP备2021116245号-1
